CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

SF3B1 mutation / ring sideroblasts (MDS)

Gene: SF3B1 · Type: mutation

Indications: Myelodysplastic syndrome

SensitivityResistanceCIViC Context

Linked CIViC Profile: SF3B1 MUTATION

Evidence Level Distribution

Level A: 1Level B: 4
LevelTypeDirectionSignificanceDiseaseDrugsRating
BPrognosticSupportsPoor OutcomeChronic Lymphocytic Leukemia5
APrognosticSupportsPoor OutcomeChronic Lymphocytic Leukemia5
BPrognosticSupportsPoor OutcomeChronic Lymphocytic Leukemia4
BPrognosticSupportsPoor OutcomeChronic Lymphocytic Leukemia4
BPrognosticSupportsBetter OutcomeMyelodysplastic Syndrome3